Quality of Life in Crohn’s Disease: What’s the Best Drug?

by | Jun 18, 2026 | Health

Risankizumab is more effective than ustekinumab in achieving sustained clinical improvements in health-related quality of life in patients with Crohn’s disease.
Medscape Medical News

Written By

Written by Albert Pham, News Curator and Blogger

Related Posts

0 Comments